Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine.

Gouri, Adel; Dekaken, Aoulia; El Bairi, Khalid; Aissaoui, Arifa; Laabed, Nihad; Chefrour, Mohamed; Ciccolini, Joseph; Milano, Gérard; Benharkat, Sadek

Gouri, Adel; Dekaken, Aoulia; El Bairi, Khalid; Aissaoui, Arifa; Laabed, Nihad; Chefrour, Mohamed; Ciccolini, Joseph; Milano, Gérard; Benharkat, Sadek.

Afiliação

Gouri A; Laboratory of Biochemistry, Faculty of Medicine, Badji Mokhtar University, Annaba, Algeria.
Dekaken A; Department of Internal Medicine, EL OKBI Public Hospital, Guelma, Algeria.
El Bairi K; Independent Research Team in Cancer Biology and Bioactive Compounds, Faculty of Medicine and Pharmacy, Mohamed 1st University, Oujda, Morocco.
Aissaoui A; Laboratory of Biochemistry, Faculty of Medicine, Badji Mokhtar University, Annaba, Algeria.
Laabed N; Laboratory of Biochemistry, Faculty of Medicine, Badji Mokhtar University, Annaba, Algeria.
Chefrour M; Laboratory of Biochemistry, La Timone University Hospital of Marseille, France.
Ciccolini J; Clinical Pharmacokinetics Laboratory, SMARTc unit, Inserm S911 CRO2, La Timone University Hospital of Marseille, France.
Milano G; Oncopharmacology Unit, Centre Antoine Lacassagne, Nice, France.
Benharkat S; Laboratory of Biochemistry, Faculty of Medicine, Badji Mokhtar University, Annaba, Algeria.

Biomark Insights ; 11: 105-11, 2016.

Article em En | MEDLINE | ID: mdl-27578963

Palavras-chave

breast cancer; precision medicine; therapy decision; urokinase plasminogen activator

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Biomark Insights Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Argélia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google